tiprankstipranks
AngioGenex Inc (AGGX)
OTHER OTC:AGGX
US Market

AngioGenex (AGGX) Income Statement

0 Followers

AngioGenex Income Statement

Last quarter (Q ), AngioGenex's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, AngioGenex's net income was $-147.38K. See AngioGenex’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 18Dec 17Dec 16Dec 08Dec 07
Total Revenue
-$ 0.00$ 0.00$ 0.00$ 0.00$ 50.00K
Cost of Revenue
----$ 0.00-
Gross Profit
----$ 0.00-
Operating Expense
$ 895.01K$ 437.66K$ 646.19K$ 437.96K$ 390.77K$ 345.93K
Operating Income
$ -895.01K$ -437.66K$ -646.19K$ -437.96K$ -390.77K$ -295.93K
Net Non Operating Interest Income Expense
$ -9.25K$ -9.25K$ -36.07K$ -10.72K$ -9.99K-
Other Income Expense
$ 156.00$ 312.00$ -768.00$ 153.00--
Pretax Income
$ -904.11K$ -446.59K$ -683.03K$ -448.53K$ -400.76K$ -364.40K
Tax Provision
$ -11.15K$ -11.15K$ 0.00$ 0.00$ 0.00-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -892.96K$ -435.45K$ -683.03K$ -448.53K$ -400.76K$ -364.40K
Basic EPS
$ -0.03$ -0.01$ -0.02$ -0.02$ -0.02$ -0.02
Diluted EPS
$ -0.03$ -0.01$ -0.02$ -0.02$ -0.02$ -0.02
Basic Average Shares
$ 119.39M$ 29.39M$ 27.76M$ 24.23M$ 21.18M$ 20.67M
Diluted Average Shares
$ 119.39M$ 29.39M$ 27.76M$ 24.23M$ 21.18M$ 20.67M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 895.01K$ 437.66K$ 646.19K$ 437.96K$ 390.77K$ 345.93K
Net Income From Continuing And Discontinued Operation
$ -892.96K$ -435.45K$ -683.03K$ -448.53K$ -400.76K$ -364.40K
Normalized Income
$ -892.96K$ -435.45K$ -683.03K$ -448.53K$ -400.76K$ -364.40K
Interest Expense
$ 9.46K$ 9.96K$ 36.44K$ 10.72K$ 10.02K-
EBIT
$ -894.65K$ -436.64K$ -646.59K$ -437.81K$ -390.75K$ -295.93K
EBITDA
$ -894.65K$ -436.64K$ -646.59K$ -437.81K$ -390.13K$ -240.88K
Currency in USD

AngioGenex Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis